Close
Nordic 9Nordic 9

Blue Cabinet (investor - Others)

Sweden
See something wrong or missing? Let us know
Offices:Norrköping
Average round investment:N/A USD
Average number per year:0.0
Distribution: 2025 (1)
Portfolio companies: Sweden FenoMark Diagnostics
Mostly invests in: Sweden Sweden (1) Health services (1)

1 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Blue Cabinet

Name Criteria
Sweden Unionen
70%
  • Range for average deal size: n/a USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Active last 12 months: Yes
Sweden Triathlon Group
70%
  • Range for average deal size: n/a USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Active last 12 months: Yes
Sweden Ekeblad Bostad
70%
  • Range for average deal size: n/a USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Active last 12 months: Yes
Sweden Malte Kuhnemund
70%
  • Range for average deal size: n/a USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Active last 12 months: Yes
United States Chris Mayle
67%
  • Range for average deal size: n/a USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Active last 12 months: Yes
United States Marc Gare
67%
  • Range for average deal size: n/a USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Active last 12 months: Yes
United States Frank Cid
67%
  • Range for average deal size: n/a USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Active last 12 months: Yes
Canada Sebastian De La Rosa
67%
  • Range for average deal size: n/a USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Active last 12 months: Yes
Germany Ortho Innovations
67%
  • Range for average deal size: n/a USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Active last 12 months: Yes
Italy Golgi NueroSciences
67%
  • Range for average deal size: n/a USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Active last 12 months: Yes
Top